Cullinan Associates Inc. decreased its holdings in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 0.1% in the second quarter, Holdings Channel reports. The fund owned 262,392 shares of the company’s stock after selling 272 shares during the period. Procter & Gamble accounts for approximately 2.8% of Cullinan Associates Inc.’s investment portfolio, making the stock its 7th largest holding. Cullinan Associates Inc.’s holdings in Procter & Gamble were worth $41,804,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Nova Wealth Management Inc. acquired a new position in shares of Procter & Gamble in the first quarter valued at approximately $26,000. Signature Resources Capital Management LLC increased its holdings in shares of Procter & Gamble by 67.9% in the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock valued at $28,000 after acquiring an additional 72 shares during the last quarter. Quarry LP purchased a new stake in Procter & Gamble during the first quarter worth approximately $33,000. Mizuho Securities Co. Ltd. lifted its position in shares of Procter & Gamble by 566.7% during the 1st quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company’s stock worth $34,000 after buying an additional 170 shares during the last quarter. Finally, Quest 10 Wealth Builders Inc. increased its position in shares of Procter & Gamble by 50.3% during the first quarter. Quest 10 Wealth Builders Inc. now owns 245 shares of the company’s stock worth $42,000 after purchasing an additional 82 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.
Procter & Gamble Price Performance
Shares of NYSE:PG opened at $152.19 on Monday. The business has a fifty day simple moving average of $155.51 and a 200-day simple moving average of $159.95. Procter & Gamble Company has a 52 week low of $149.91 and a 52 week high of $180.43. The company has a market cap of $356.20 billion, a P/E ratio of 23.38, a P/E/G ratio of 4.02 and a beta of 0.36. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49.
Procter & Gamble Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were paid a $1.0568 dividend. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble’s payout ratio is currently 64.82%.
Insiders Place Their Bets
In related news, CFO Andre Schulten sold 11,638 shares of the company’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the completion of the sale, the chief financial officer directly owned 52,642 shares of the company’s stock, valued at approximately $8,279,007.34. This represents a 18.11% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Jon R. Moeller sold 40,119 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $6,309,515.13. Following the completion of the transaction, the chief executive officer owned 319,375 shares of the company’s stock, valued at approximately $50,228,106.25. This represents a 11.16% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 120,181 shares of company stock worth $18,918,012. 0.20% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
A number of brokerages have weighed in on PG. BNP Paribas reiterated an “outperform” rating and issued a $177.00 price objective on shares of Procter & Gamble in a research note on Friday, August 15th. BNP Paribas Exane cut their price target on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research note on Tuesday, September 23rd. UBS Group set a $180.00 target price on Procter & Gamble and gave the stock a “buy” rating in a research note on Wednesday, July 30th. Evercore ISI reiterated an “in-line” rating and issued a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Procter & Gamble in a report on Saturday, September 27th. Eleven research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $173.11.
View Our Latest Research Report on PG
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
- Five stocks we like better than Procter & Gamble
- 3 Dividend Kings To Consider
- 3 Defense Stocks Surging as Ukraine Tensions Deepen
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Starbucks Stock Slumps; This Competitor Shows Strength
- The Basics of Support and Resistance
- The Trade Desk: 2 Signs of a Comeback, 1 Risk Ahead
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.